Abstract
The plasma proteome can mediate associations between periodontal disease (Pd) and brain white matter integrity (WMI). We screened 5089 UK Biobank participants aged 40–70 years for poor oral health problems (POHP). We examined the association between POHP and WMI (fractional anisotropy (FA), mean diffusivity (MD), Intracellular Volume Fraction (ICVF), Isotropic Volume Fraction (ISOVF) and Orientation Diffusion (OD)), decomposing the total effect through the plasma proteome of 1463 proteins into pure mediation, pure interaction, neither, while adjusting for socio-demographic and cardiovascular health factors. Similarly, structural equations modeling (SEM) was conducted. POHP was more prevalent among men (12.3% vs. 9.6%), and was associated with lower WMI on most metrics, in a sex-specific manner. Of 15 proteins strongly associated with POHP, growth differentiation factor 15 (GDF15) and WAP four-disulfide core domain 2 (WFDC2; also known as human epididymis protein 4; HE4) were consistent mediators. Both proteins mediated 7–8% of total POHP effect on FAmean. SEM yielded significant total effects for FAmean, MDmean and ISOVFmean in full models, with %mediated by common latent factor (GDF15 and WFDC2) ranging between 13% (FAmean) and 19% (ISOVFmean). For FA, mediation by this common factor was found for 16 of 49 tract-specific and global mean metrics. Protein metabolism, immune system, and signal transduction were the most common pathways for mediational effects. POHP was associated with poorer WMI, which was partially mediated by GDF15 and WFDC2.
Similar content being viewed by others
Introduction
Dementia is a leading cause of death and disability and its impact on population health is expected to rise in response to population aging [1, 2]. Risk factors for Alzheimer’s disease (AD)—the leading cause of dementia [2, 3]—include older age, family history, and genetics, with the APOE4 allele being the main genetic risk factor [2]. The 2020 Lancet commission identified 40% of dementia cases as attributed to 12 modifiable risk factors that at midlife may have an impact on the emergence of neuropathology and have been associated with early brain markers of neurodegeneration [4].
Recent studies identified systemic and CNS-based infectious pathogens as potential risk factors for AD and other forms of neurodegenerative diseases. Infectious agents are hypothesized to cause AD through CNS infiltration, severe systemic inflammation, or by inducing autoimmunity in response to certain pathogens. The polymicrobial hypothesis has been proposed as a more logical process for AD pathogenesis [5]. Periodontal bacteria (Porphyromonas gingivalis (P. gingivalis), Tannerella forsythia (T. forsythia), Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), Treponema denticola (T. denticola)) are responsible for periodontal disease (Pd) [6], which can result in gingival inflammation, connective tissue deterioration, periodontal pocket development, alveolar bone loss, and tooth loss. A recent investigation found that P. gingivalis and resulting gingipains in the brain play a critical role in AD etiology and that Aβ1-42 is produced in the brain partly as a reaction to this infection. Epidemiological data connecting Pd-related illnesses, including P. gingivalis, to AD or early markers of neurodegeneration associated with AD, however, is scarce.
Magnetic resonance imaging (MRI) is a useful tool for identifying and quantifying vascular brain injuries and structural abnormalities. Diffusion-Weighted Imaging (DWI) measures tissue-level water diffusion rate, detecting water movement within tissue architecture [7]. DTI indices provide quantitative probes of the magnitude and directionality of water molecules. Fractional anisotropy (FA) reflects the directionality of molecular displacement by diffusion, with values between 0 and 1; higher values are an indicator of anisotropic diffusion that confers a preferred direction, whereas mean diffusivity (MD) reflects the average magnitude of molecular displacement by diffusion, with higher values indicating more freely diffusing water [7, 8]. FA and MD are proxies of neuronal status, including axonal, myelin, dendritic, and synaptic integrity.
Although DTI-indices are sensitive to capture early changes in tissue microstructure, they are lacking specificity to different diffusion tissue compartments. To overcome this difficulty, the neurite orientation dispersion and density imaging (NODDI) MRI technique has been introduced [9, 10]. Indeed, studies have shown that NODDI derived outcomes are more sensitive and specific to clinical outcomes and target pathologies as compared to DTI-indices [9, 10]. Indeed, NODDI provides measures of the orientation dispersion index (OD or ODI), intracellular volume fraction (ICVF), generally defined as the neurite density index (NDI), and volume fraction of the isotropically diffusing water (ISOVF) [11]. NDI/ICVF reflects the intrinsic water molecules transport within the axons or neurites, ISOVF provides a measure of the freely-diffusing water, while OD indicates the dispersion extent of the neurites or axons [11]. Both ISOVF and OD are expected to be negatively correlated with brain health, whereas ICVF integrity, is expected to be positively correlated with brain health with higher values indicating greater neurite density or integrity [11]. Recent studies have shown that POHP or specifically Pd, were associated with poorer WMI and other brain MRI markers of the dementia phenome [12, 13]. Studies suggest that the plasma proteome may be connected to all-cause dementia [14,15,16,17,18,19], though little is known about whether the proteome may be influenced by Pd in relation to early neuroimaging markers of dementia [9, 20].
The associations of Pd and poor oral health problems (POHP) with MRI-based markers of dementia remain underexplored. We examined associations of POHP with several dementia phenome-related brain MRI DTI and NODDI metrics of WMI among dementia-free older adults, focusing on mediation through the plasma proteome, and using data from the UK Biobank.
Methods
Database
The UK Biobank surveyed more than 500,000 UK residents between the ages of 37 and 73 over the period of 2006 through 2010 [21]. Study details are discussed elsewhere [21]. Participants were evaluated by qualified staff who collected biological samples and phenotypic measurements [22]. The Northwest Multi-Centre Research Ethics Committee approved the UK Biobank. The Institutional Review Board of the National Institutes of Health and the UK Biobank access management team both gave their consent to this project as part of application #77963.
Study sample
Figure 1 depicts the participant flowchart starting from the initial sample of 502,366 UK Biobank participants, of whom only 5089 had neuroimaging data, other key covariates of interest and proteomic data measured at baseline assessment (2006–2010), and who were also dementia-free at baseline.
Brain MRI acquisition and processing
Brain MRIs were performed on a subset of UK Biobank participants in an ongoing ancillary study (45k participants up to October of 2022; initiated in 2014) at three MRI locations spread across the study area [23, 24]. All brain MRI data were acquired using similar 3T Siemens Skyra scanners, according to a freely available protocol (http://www.fmrib.ox.ac.uk/ukbiobank/protocol/V4_23092014.pdf), with documentation and published methods, including the image processing and QC pipeline, available at: http://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf.
Briefly, the UK biobank team analyzed white matter tract-averaged diffusion MRI (dMRI) indices and made them available to approved researchers as imaging-derived phenotypes (IDPs), which included the DTI and NODDI metrics (see Online Supplementary Methods (OSM) 1 for more details). Here, we limited the IDPs to the available DTI and NODDI measures, including FA, MD, ISOVF, ICVF, and ODI across white matter tracts [25]. The key outcomes of interest were tract-averaged global means of FA, MD, ISOVF, ICVF and OD, with tract-specific values deemed secondary outcomes of relevance, and details provided in Online Supplementary Methods (OSM) 1.
Poor oral health problems, POHP
POHP (yes = 1 vs. no = 0) were derived from self-report indicating “loose teeth” or “dentures” or diagnosed Pd included UKB field code 131562 (“Date K05 first reported (gingivitis and periodontal diseases)), including all sources of data (e.g. outpatient and hospitalization) as long as those occurred prior to baseline assessment. Report of both loose teeth and denture was excluded as unexposed, given that partial loose teeth with denture may be considered as “treated” severe oral health problem, while “denture only” is considered a severe advanced stage with potential for complete edentulation. The two self-report questions were chosen due to their strong genetic correlation with periodontitis and tooth loss, respectively [26]. This main exposure and its rationale is comparable to the one used by another study with similar objectives, excluding proteomic analyses [27]. A sensitivity analysis for association with the key outcome FAmean was carried out on three alternative exposure definitions: (i) “severe reported health problems including both dentures and loose teeth: 0 = none, 1 = one and 2 = both”, irrespective of diagnosis; (ii) “ diagnosed prevalent periodontal disease, yes vs. no”; and (iii) all self-reported oral problems (yes vs. no), including loose teeth, dentures, mouth ulcers, toothache, painful gums and bleeding gums, irrespective of diagnosis; (iv) proxy measure for self-reported Pd, as described by previous studies, which included self-reported painful gums, bleeding gums and/or having loose teeth [28].
Olink proteomics
Olink® Explore 1536 Proteomics platform was used for proteome analysis of 54,306 plasma samples from distinct UK Biobank participant-visits as part of the UK Biobank Pharma Proteomics Project (UKB-PPP), 1472 protein analytes—corresponding to 1463 distinct proteins—from panels for inflammation, cancer, cardiometabolic, and neurological conditions—were measured using Proximity Extension Assay (PEA) technology. Sun et al. provides information on the PEA tests, normalization, and pre-processing of the data [29]. Normalized protein expression (NPX) units on a log2 scale are used, to represent protein data [29]. Since the proteins are already Log2 transformed and normally distributed, we have only modified them to standardized z-scores within the final largest selected sample.
Covariates
We included age, sex, race/ethnicity (White, Black, South Asian, and Others), and household size as well as the Townsend deprivation index (TDI), pre-tax household income (1 = “£18,000,” 2 = “£18,000–£29,999,” 3 = “£30,000–£51,999,” 4 = “£52,000–£100,000,” and 5 = “ > £100,000), and educational accomplishment (0 = Low, combining “None,” “CSEs/Equivalent,” “NVQ/HND/HNC/Equivalent,” and “Other professional qual”; 1 = Intermediate, combining “O Levels/GCSEs/Equivalent,” and “A/AS Levels Equivalent”; and 2 = Higher level) [30]. TDI ratings were computed using national census data, accounting for residential postcode-level car ownership, crowded housing, owner occupation, and unemployment. A higher TDI score denotes socioeconomic deprivation [31]. To reflect higher socioeconomic status (SES), TDI was multiplied by −1 and mixed with z-scores for household income and educational attainment to create a single SES summary score. Potential confounding variables included a composite measure of cardiovascular health, known as the American Heart Association’s “Life’s Essential 8” (LE8). Supplementary Method 2 and Supplementary Tables 1–3 include specifics about this measure.
Statistical analysis
Stata 18.0 (StataCorp, College Station, Texas) was used for all analyses, while data visualization was partly accomplished using R version 4.3.1. The overall and sex stratified sample’s means and proportions of important study characteristics were determined. Additionally, the same estimates were contrasted by sex using multinomial, logistic, and linear logit models. To investigate the adjusted relationships of POHP exposure on the various WMI parameters, multiple linear regression models were used, adjusting for baseline age, sex, race, SES, household size and LE8 total score. In most analyses where sex was the main stratifying factor, regression models were conducted on the total sample as well as separately on men and women. With simultaneous correction for the same covariates (Stata parmby, qqval, and multproc commands), POHP was included to a series of distinct multiple linear regression models, with outcomes alternating among 1463 plasma proteomic biomarkers. To display the p-values and effect sizes of each of the 1463 equations and to highlight those that passed multiple testing with the Bonferroni adjustment, a volcano plot was made using the R ggplot package. The top hits with >0.25 effect size in absolute value (corresponding to ¼ SD higher plasma protein value among the POPH+ group vs. POHP−) were selected among those who passed Bonferroni correction. This effect size is considered to be weak to moderate based on several guidelines (https://cran.r-project.org/web/packages/effectsize/vignettes/interpret.html). A weaker effect size threshold was chosen if needed, corresponding the top 99th percentile (or 1st and 99th percentile on either side), with the goal of reducing the number of selected proteins to <30 for this part of the analysis. A similar approach was applied previously in comparable studies testing plasma proteomics from the UK Biobank against other exposures [32,33,34].
These selected biomarkers were then included in a four-way decomposition model with one of each selected proteomic marker as the mediator, POHP as the primary exposure, FAmean as the primary outcome (z-scored), means of other WMI measures (MDmean, ISOVFmean, ICVFmean and ODmean, z-scored) as secondary outcomes, and a linear model as the final equation (Supplementary Method 3) [35]. All these models were adjusted for baseline age, sex, race, SES, household size and LE8 total score. These markers were also allowed to attenuate the relationship between POHP and WMI. The results are displayed as tabular data with heatmap graphics. The top discovered mediators in the POHP-WMI interaction are highlighted based on their function and connection to POHP and neurodegeneration in earlier investigations.
A principal components analysis (PCA) included any of the pre-selected plasma proteins that were statistically significant mediators with a positive or inverse pure indirect effect at type I error of 0.05 and a statistically significant total effect in the same direction. For ease of comprehension, numerous components that were retrieved underwent orthogonal rotation using varimax. When more than one component was extracted, the Kaiser rule (eigenvalue > 1) was used to determine how many components were extracted. Those PCA scores (z-scores) were forecasted using the regression approach and included in another set of 4-way decomposition models to examine the extent of mediation and/or moderation by these components in the overall effect of POHP on each of the five WMI indicators (z-scored). POHP was used as the exposure, and a structural equations model was used to conduct a sensitivity analysis by adding an increasing number of exogenous factors and calculating the total, direct, and indirect effects from these models with possible final outcomes. The same four-way decomposition models used for the global mean WMI metrics were used for a secondary analysis with tract-specific WMI metrics.
The supplemental materials also contain results for significant pure indirect effects (PIE) across the whole proteome (i.e., k = 1463 proteins). These results were entered into the OLINK insight pathways browser (https://github.com/baydounm/UKB-paper10-supplementarydata) to determine the most common pathways used by those mediators in relation to each of the five WMI metrics, which was then displayed as a collection of independent and connected pathways.
Other sensitivity analyses were conducted: (i) Structural Equations Models described above were further adjusted for key time lag variables, including fasting time, season and time between baseline assessment and the neuroimaging visit and time from blood draw to processing of samples for proteomics; (ii) The larger set of plasma proteins which was made available end of 2023 (~3000 proteins) was utilized to conduct part of the analysis, including screening for significant and strong association with POHP, and four-way decomposition models for the selected plasma proteins to detect additional consistent mediators; (iii) POHP was tested as a predictor for all WMI mean measures in the largest available sample with complete dMRI neuroimaging data, including among participants who were excluded due to non-available plasma proteins.
Results
Table 1 displays the distributions of those key variables overall and stratified by sex. POHP was more prevalent among male (12.3%) compared with female adults (9.6%) in this sample (P < 0.001). Sex differences were also notable with an average higher SES z-score among male adults, in contrast with LE8 total and component scores which indicated better cardiovascular health among female adults. Female adults were younger and had on average a smaller household size compared to their male counterparts. Importantly, there were sex differences in both mean MD and mean ISOVF, indicating better brain white matter microstructural integrity (WMI) among female compared to male adults (P < 0.001), with no difference detected for FA, ICVF or OD.
Table 2 shows the overall and sex-specific association between POHP and brain WMI, after adjusting for key potentially confounding covariates. POHP was associated with most metrics of brain WMI, with the exposed group having lower WMI compared to the unexposed. In the overall sample, this pertained to FAmean, MDmean and ISOVFmean. Interestingly, the positive association between POHP and ISOVFmean was only detected among men, for whom no other POHP-WMI metric association was found. In contrast, among women, POHP was associated with poorer WMI only in terms of lower FAmean and reduced ICVFmean (β < 0, P < 0.05). A sensitivity analysis carried out including all available data – i.e. with or without plasma proteomics data -- found similar results which are detailed in Supplementary Table 4. One notable difference was no detectable difference in mean ICVFmean by POHP among women, while overall, POHP was associated with lower ICVFmean.
We evaluated 1463 multiple linear regression models to examine the strongest relationships between POHP and the plasma proteome. Only 15 plasma proteins were significantly predicted by POHP after Bonferroni correction, all of which passed the effect size restriction of a beta that was either <−0.15 or >+0.15, reflecting ~1/7-1/6 SD difference between POHP+ and POHP- groups in Log2 transformed and z-scored proteins. The key findings are shown as a volcano plot (Fig. 2). Selected strongly associated proteins in their standardized z-scored form with POHP (k = 15) were included into a four-way decomposition models with alternative outcomes being the 5 dMRI metrics, FAmean, MDmean, ICVFmean, ISOVFmean and ODmean (all z-scored) and all equations being multivariable-adjusted linear regression models. As in the previous analyses, potentially confounding covariates were baseline age, sex, race, SES, household size and LE8 total score.
Table 3, Fig. 3 (both focused on FAmean) and supplementary datasheet 1 (all five WMI metrics) present key findings and indicate two of the strongest plasma proteome mediators were growth differentiation factor 15 (GDF15) and WAP four-disulfide core domain 2 (WFDC2; also known human epididymis protein 4; HE4), which consistently and partially mediating the association between POHP and at least 2 of the five WMI metrics. In contrast, in the case of FAmean (Table 3 and Fig. 3), 12 of the 15 proteins did not act as mediators, while one had a mediating effect that was in the opposite direction to the total effect (TNFRSF4), indicating that for the most part, POHP had a direct inverse effect on FAmean that was not explained by the strongest proteomic predictors of this exposure. The 2 mediators of 15 (i.e. GDF15 and WFDC2) which showed a consistently significant pure indirect effect along with a total effect of POHP with P < 0.05, are shown in supplementary Table 5 with descriptions of their main biological functions and links to POHP and neurodegeneration based on previous studies. GDF15 and WFDC2, mediated about 7–8% of total effect of POHP on FAmean (PIE < 0, TE < 0, P < 0.05) (Table 3 and Fig. 3). Other WMI metrics whereby GDF15 acted as a potential mediator of the main association of interest included MDmean and ISOVFmean, whereas this was the case for WFDC2 for MDmean and ICVFmean. In both cases (i.e. for GDF-15 and WFDC2), TE was also detected and in the same direction as PIE (Supplementary Datasheet 1). Most notably, GDF15 explained around 13% of the POHP-ISOVFmean association based on the PIE as percent of TE, while WFDC2 explained over 15% of the POHP-ICVFmean association. This percentage was 8–9% in the case of MDmean for those two key proteomic mediators. A sensitivity analysis was conducted using up to 2920 plasma protein made available in November of 2023 to our UKB project. The same exercise was carried out whereby the strongest associations between POHP and each protein were screened for using Bonferroni correction and an absolute value for the effect size set to 0.15, while adjusting for potentially confounding covariates. This resulted in only 12 proteins being selected. Most of the previously selected 15 proteins were retained, including GDF15 and WFDC2. None of the newly selected proteins (RNASE6 and TNFRSF1A) were found to be significant mediators based on a statistically significant PIE at a type I error of 0.05. It is worth noting that the new batch of proteins had markedly smaller sample sizes compared to the older batch, resulting in a reduced statistical power to detect an association with POHP or mediation between POHP and each WMI metric. The full Output is provided in: https://github.com/baydounm/UKB-paper10-supplementarydata.
A single PCA factor was extracted from those two key significant proteomic mediators (GDF15 and WFDC2) which was then entered into another series of four-way decomposition and structural equations models (as a sensitivity analysis). This PCA factor explained part of a statistically significant total effect of POHP in the case of FAmean and MDmean only, as depicted in Fig. 4, Panel A. A similar finding was observed in a series of SEM models (Supplementary Datasheet 2 and Fig. 4), that were incrementally adjusted for different sets of exogenous variables. The full model included all the exogenous variables that were entered in four-way decomposition models. Similar to our main models, SEM models indicated that the total effects of POHP on FAmean, MDmean and ISOVFmean were statistically significant indicating a deleterious effect of POHP on WMI. Nevertheless, in these models, partial mediation by the PCA score encompassing GDF15 and WFDC2, was observed for all 3 WMI metrics, with percent mediated ranging between 13% for FAmean and 19% for ISOVFmean (Fig. 4, Panel B, Full Model 1). Inclusion of fasting time (hours), season when baseline assessment was carried out and time from baseline assessment to the neuroimaging visit (days) as additional exogenous covariates to the fully adjusted model did not alter findings significantly (Fig. 4, Panel B, Full Model 2).
Tract-specific results were also explored as a secondary analysis with the common PCA mediator (GDF15 and WFDC2) between Pd and all five WMI metrics. Results are presented in Supplementary Datasheet 3 and visualized in Fig. 5. Total effect of Pd on tract-specific FA was noted in 16 of the 49 tract-specific and global mean metric investigated, with partial mediation seen for the anterior corona radiata (ACR, L/R), body of the corpus callosum (BCC), the cerebellar peduncle (CP, L/R), external capsule (EC, L), fornix cres+stria terminalis (FCST, L/R), the genu of corpus callosum (GCC), the medial lemniscus (L/R), posterior thalamic radiation (PTR, L/R), superior cerebellar peduncle (SCP, L/R), and the Left fronto-occipital fasciculus (FOF, L), all exhibiting negative associations. Several of these tract-specific associations were also seen for other WMI metrics, including MD and ISOVF with positive associations, as expected (Fig. 5 and Supplementary Datasheet 3).
We performed OLINK insight pathway analysis including all statistically significant mediators with PIE < 0.05 (k = 6 proteins for FAmean, k = 7 for MDmean, k = 3 for ICVFmean, k = 3 for ISOVFmean, and k = 5 for OD), irrespective of whether those were initially selected using Bonferroni correction. Pathways that were in common to all five phenotypes included metabolism of proteins, while the immune system and signal transduction appeared to be involved in the pathway between POHP and WMI for 4 out of 5 metrics. Detailed pathways for each phenotype are presented in Supplementary Datasheet 4 and visualized in Fig. 6. All supplementary datasheets, detailed code and related result datasets used to generate the Figures and Tables are provided in: https://github.com/baydounm/UKB-paper10-supplementarydata.
Finally, a sensitivity analysis indicated that FAmean was reduced for 3 of the 4 alternative exposures defined earlier, excluding the poor oral health self-reported exposure that combined both severe and non-severe conditions. In contrast, the PCA score for GDF15 and WFDC2 was only significantly increased in one alterative exposure of four, namely the severe self-reported oral problems, 0 = None, 1 = either dentures or loose teeth and 2 = Both. This sensitivity analysis is made available on github at : https://github.com/baydounm/UKB-paper10-supplementarydata.
Discussion
We used four-way decomposition models to evaluate the total POHP effect on selected MRI-based brain measures through plasma proteomic biomarkers among a sample of 5089 UK Biobank participants aged 40–70 years. We observed an inverse association between POHP and WMI on most metrics, in a sex-specific manner. Of 15 plasma proteins strongly associated with POHP, GDF15 and WFDC2 were consistent mediators. Both plasma proteins mediated about 7–8% of total effect of POHP on FAmean (PIE < 0, TE < 0, P < 0.05). SEM yielded significant total effects for FAmean, MDmean and ISOVFmean in full models, with percent mediated by a common latent factor for GDF15 and WFDC2 ranging between 13% for FAmean and 19% for ISOVFmean. Significant mediation by this common factor was mostly found for 16 out of 49 tract-specific and global mean metrics, in the case of FA. Metabolism of proteins, immune system and signal transduction were the most common pathways involved in these mediational effects.
Recent studies have shown that POHP or specifically Pd, were associated with poorer WMI and other brain MRI markers of the dementia phenome [12, 13]. For instance, a recent study investigated the relationship between the number of teeth present (NTP) and hippocampal atrophy in late middle-aged and older adults. Results suggested that fewer teeth were associated with a faster rate of left hippocampal atrophy in patients with mild periodontitis, while having more teeth was linked to a faster rate of atrophy in those with severe periodontitis [12]. Furthermore, The PAROBRAIN study examined the link between periodontal health, WMI, and cerebral small vessel disease in the Hamburg City Health Study. Results showed that increased white matter hyperintensity was associated with more CAL, plaque index, and tooth loss [13]. Similar to these previous studies, we found that POHP was associated with poorer WMI, using a set of pre-clinical measures that are highly predictive of dementia incidence. This association was found among both men and women, though for different WMI metrics.
The relationships between Pd and dementia are complicated and may include systemic factors, shared risk factors, chronic inflammation, and the presence of bacteria [36,37,38,39,40]. Although these pathways have not been proven, they provide information about a potential connection between these two illnesses. For instance, Pd causes long-lasting gum inflammation and releases cytokines and pro-inflammatory chemicals into the bloodstream [39, 40]. These inflammatory molecules may enter the brain and contribute to neuroinflammation, a characteristic of dementia. Additionally, inflammation may compromise the blood-brain barrier, allowing inflammatory agents and germs from the oral cavity to enter the brain and possibly accelerate cognitive impairment. These bacteria may then cause an immunological reaction that damages and inflames the brain. Studies have even found periodontal bacteria in brain samples from dementia patients, indicating a potential link [36,37,38,39,40]. Another element that might be important is systemic inflammation [39, 40]. A systemic inflammatory condition that is brought on by persistent Pd inflammation has been linked to several chronic illnesses, including dementia [39, 40]. Finally, Pd and dementia risk factors that are similar are probably involved [39, 40]. Age, genetic and biological variables, lifestyle decisions including smoking, and other risk factors are all shared by Pd and dementia [36, 37]. While these proposed routes shed light on the correlations between Pd and dementia that have been identified, more investigation is required to establish causal links and identify the precise processes at work. However, treating Pd may have wider effects on overall health, including brain health, highlighting the need of good oral hygiene as a potential preventive practice for dementia.
Our study suggests that specific circulating proteins as well as several pathways are involved in mediating Pd’s association with poorer WMI. One key protein found to be an important mediator between POHP and WMI was WFDC2. WFDC2, also known as human epididymal protein 4 (HE4), is a secreted glycoprotein that may play a role in periodontal health through extracellular matrix remodeling. A recent study using data from National Health and Nutrition Examination Survey (NHANES) 2001–2002, found that in women (n = 1715) over the age of 30 that high serum levels of HE4 were associated with Stage III/IV periodontitis [41]. Serum HE4 levels were associated with cognitive decline in patients with diabetes mellitus [42] and with cognitive decline and dementia in the British Whitehall II and US Atherosclerosis Risk in Communities (ARIC) studies [18]. However, HE4 has not been extensively studied in relation to brain MRI markers of the dementia phenome.
Among the most important mediators was GDF15, which is a stress-response protein that plays a multitude of roles in disease processes, but recently has been linked to the immunological response to infection [34, 43] as well as playing a potential role in cognition and dementia [19, 44, 45]. There is some evidence that GDF15 may also play a role in Pd [46,47,48,49]. Emerging evidence has also connected GDF15 to cognition, dementia, and AD [44, 50,51,52,53,54]. In a recent study, GDF15 and NT-proBNP were associated with increased risk of incident all-cause and AD dementia in individuals over 60 years [54]. These biomarkers improved dementia risk classification beyond traditional clinical risk factors, indicating their potential for predicting dementia incidence. The same study also showed that elevated GDF15 was associated with lower total brain and hippocampal volumes, greater white matter hyperintensity volume, and poorer cognitive performance [54]. Another study of older individuals found that mean FA values globally and in various brain regions were negatively associated with GDF15 serum levels. Tract-specific findings were comparable to our present study, particularly the inverse association with FA in the corpus callosum, the posterior thalamic radiation [55]. An earlier study examined the relationship between GDF15 levels and human brain gray matter (GM) volumes in a community-dwelling sample aged 70–90 years [56]. Results showed significant negative associations between GDF15 serum levels and both subcortical and cortical GM volumes [56]. Increases in GDF15 serum levels were associated with decreases in GM volumes over two years [56]. Similarly, in the Framingham Offspring cohort study, higher GDF15 was linked to greater white matter hyperintensity volumes [57].
Our current study has many strengths with notable limitations. First, this study examined a wide-scale proteomic analysis in a large cohort, and it is the first cohort study with sufficient power to assess the plasma proteome’s mediating and moderating effects in the relationship between Pd and measures of brain white matter microstructural integrity. Second, using specific diagnosis dates received through record linkage, UK Biobank investigators generated diagnosed Pd among others. Third, the UK Biobank includes a broad range of topics, allowing for unbiased estimates of exposure-outcome relationships via confounder adjustment. Potential study limitations include selection bias due to missing data and measurement error induced by employing self-report and ICD-10 codes. The definition of the exposure required making a choice between several combinations of both, even though a partial sensitivity analysis was carried out on other key exposure definitions. Although key confounders were accounted for, residual confounding is possible due to the observational nature of this study. Furthermore, while prevalent dementia cases were excluded up to three years after baseline assessment, reverse causality remains a possible explanation for the association between Pd and sub-clinical phases of dementia. Further, while highly sensitive to capturing early damage to cerebral tissue microstructure, DTI indices are not specific to any underlying determinant of the brain tissue, which hampers specific interpretation of the results [58,59,60]. While the NODDI analysis has been introduced to provide more specificity to neurite degeneration and dispersion through ICVF and OD metrics, derived values using NODDI suffer from various experimental and modeling limitations. Indeed, derived ICVF and ISOVF parameters have been shown to be sensitive to the choice of the echo time and the underlying assumptions of the fixed diffusivity parameters adopted in the NODDI modeling [58,59,60]. Therefore, further examinations are still required to validate our results. Moreover, four-way decomposition method has assumptions and limitations that are discussed elsewhere [35]. Finally, because the UK Biobank is underpowered for such analyses, our analyses did not stratify by racial/ethnic groupings. Future research should strive to include a stratified analysis across all main racial/ethnic groups using a larger sample of the UK biobank.
Conclusions
In summary, POHP was linked to lower WMI, which was mediated in part by two major plasma proteins, GDF15 and WFDC2. Future research should focus on other common infection types as well as inflammatory conditions that have previously been shown to predict dementia incidence, determining whether similar mechanisms are involved across types of infections and inflammatory conditions, and assessing the validity of these findings in populations at highest risk for dementia in the UK.
Data availability
The data analyzed in this study is subject to the following licenses/restrictions: UK Biobank is a large-scale biomedical database and research resource, containing in-depth genetic and health information from half a million United Kingdom participants. The database is regularly augmented with additional data and is globally accessible to approved researchers undertaking vital research into the most common and life-threatening diseases. Requests to access these datasets should be directed to https://www.ukbiobank.ac.uk/.
References
Guerchet M, Prince M, Prina M. Numbers of people with dementia worldwide: An update to the estimates in the World Alzheimer Report 2015. Alzheimer's Disease International: 2020 https://www.alzint.org.
Alzheimer’s Association. 2023 Alzheimer’s Disease Facts and Figures. Alzheimer’s Association: 2023 https://www.alz.org/alzheimers-dementia/facts-figures.
Helmer C, Pasquier F, Dartigues JF. Epidemiology of Alzheimer disease and related disorders. Med Sci. 2006;22:288–96.
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413–46.
Mawanda F, Wallace R. Can infections cause Alzheimer’s disease? Epidemiol Rev. 2013;35:161–80.
Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809–20.
Soares JM, Marques P, Alves V, Sousa N. A hitchhiker’s guide to diffusion tensor imaging. Front Neurosci. 2013;7:31.
Jones DK. Studying connections in the living human brain with diffusion MRI. Cortex. 2008;44:936–52.
Colgan N, Siow B, O’Callaghan JM, Harrison IF, Wells JA, Holmes HE, et al. Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer’s disease. Neuroimage. 2016;125:739–44.
Kamiya K, Hori M, Aoki S. NODDI in clinical research. J Neurosci Methods. 2020;346:108908.
Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage. 2012;61:1000–16.
Yamaguchi S, Murakami T, Satoh M, Komiyama T, Ohi T, Miyoshi Y, et al. Associations of Dental Health With the Progression of Hippocampal Atrophy in Community-Dwelling Individuals: The Ohasama Study. Neurology. 2023;101:e1056–e1068.
Mayer C, Walther C, Borof K, Nagele FL, Petersen M, Schell M, et al. Association between periodontal disease and microstructural brain alterations in the Hamburg City Health Study. J Clin Periodontol. 2023. https://doi.org/10.1111/jcpe.13828.
Harris SE, Cox SR, Bell S, Marioni RE, Prins BP, Pattie A, et al. Neurology-related protein biomarkers are associated with cognitive ability and brain volume in older age. Nat Commun. 2020;11:800.
Trares K, Bhardwaj M, Perna L, Stocker H, Petrera A, Hauck SM, et al. Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study. Alzheimers Res Ther. 2022;14:128.
Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease. Acta Neuropathol Commun. 2019;7:169.
Tanaka T, Lavery R, Varma V, Fantoni G, Colpo M, Thambisetty M, et al. Plasma proteomic signatures predict dementia and cognitive impairment. Alzheimers Dement. 2020;6:e12018.
Lindbohm JV, Mars N, Walker KA, Singh-Manoux A, Livingston G, Brunner EJ, et al. Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies. Alzheimers Dement. 2022;18:612–24.
Guo Y, You J, Zhang Y, Liu WS, Huang YY, Zhang YR, et al. Plasma proteomic profiles predict future dementia in healthy adults. Nat Aging. 2024;4:247–60.
Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer’s disease. Brain. 2010;133:529–39.
Mutz J, Roscoe CJ, Lewis CM. Exploring health in the UK Biobank: associations with sociodemographic characteristics, psychosocial factors, lifestyle and environmental exposures. BMC Med. 2021;19:240.
Ho FK, Gray SR, Welsh P, Gill JMR, Sattar N, Pell JP, et al. Ethnic differences in cardiovascular risk: examining differential exposure and susceptibility to risk factors. BMC Med. 2022;20:149.
Navale SS, Mulugeta A, Zhou A, Llewellyn DJ, Hypponen E. Vitamin D and brain health: an observational and Mendelian randomization study. Am J Clin Nutr. 2022;116:531–40.
de Groot M, Vernooij MW, Klein S, Ikram MA, Vos FM, Smith SM, et al. Improving alignment in Tract-based spatial statistics: evaluation and optimization of image registration. Neuroimage. 2013;76:400–11.
Beydoun MA, Beydoun HA, Gale SD, Hedges D, Weiss J, Li Z, et al. Cardiovascular health, infection burden and their interactive association with brain volumetric and white matter integrity outcomes in the UK Biobank. Brain Behav Immun. 2023;113:91–103.
Shungin D, Haworth S, Divaris K, Agler CS, Kamatani Y, Keun Lee M, et al. Genome-wide analysis of dental caries and periodontitis combining clinical and self-reported data. Nat Commun. 2019;10:2773.
Rivier CA, Renedo D, de Havenon A, Gill TM, Payabvash S, Sheth KN, et al. Poor Oral Health Is Associated with Worse Brain Imaging Profiles. medRxiv. 2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055602/pdf/nihpp-2023.03.18.23287435v1.pdf.
Jordao HW, McKenna G, McMenamin UC, Kunzmann AT, Murray LJ, Coleman HG. The association between self-reported poor oral health and gastrointestinal cancer risk in the UK Biobank: A large prospective cohort study. United European Gastroenterol J. 2019;7:1241–9.
Sun BB, Chiou J, Traylor M, Benner C, Hsu YH, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622:329–38.
Chadeau-Hyam M, Bodinier B, Vermeulen R, Karimi M, Zuber V, Castagne R, et al. Education, biological ageing, all-cause and cause-specific mortality and morbidity: UK biobank cohort study. EClinicalMedicine. 2020;29-30:100658.
Townsend P, Phillimore P, Beattie A. Health and deprivation: inequality and the North. Andover: Croom Helm; 1987.
Beydoun HA, Beydoun MA, Noren Hooten N, Weiss J, Li Z, Georgescu MF, et al. Mediating and moderating effects of plasma proteomic biomarkers on the association between poor oral health problems and incident dementia: The UK Biobank study. Geroscience. https://doi.org/10.1007/s11357-024-01202-3. Online ahead of print. 2024.
Beydoun MA, Beydoun HA, Hu YH, Maino Vieytes CA, Noren Hooten N, Song M, et al. Plasma proteomic biomarkers and the association between poor cardiovascular health and incident dementia: The UK Biobank study. Brain Behav Immun. 2024;119:995–1007.
Beydoun MA, Beydoun HA, Noren Hooten N, Meirelles O, Li Z, El-Hajj ZW, et al. Hospital-treated prevalent infections, the plasma proteome and incident dementia among UK older adults. iScience. 2023;26:108526.
Discacciati A, Bellavia A, Lee JJ, Mazumdar M, Valeri L. Med4way: a Stata command to investigate mediating and interactive mechanisms using the four-way effect decomposition. Int J Epidemiol. 2019, 15–20. https://doi.org/10.1093/ije/dyy236.
Allwright M, Mundell HD, McCorkindale AN, Lindley RI, Austin PJ, Guennewig B, et al. Ranking the risk factors for Alzheimer’s disease; findings from the UK Biobank study. Aging Brain. 2023;3:100081.
Larvin H, Gao C, Kang J, Aggarwal VR, Pavitt S, Wu J. The impact of study factors in the association of periodontal disease and cognitive disorders: systematic review and meta-analysis. Age Ageing. 2023;52:afad015.
Noble JM, Papapanou PN. With Teeth, Broken, or Fixed: The Challenges of Linking Periodontitis, Neuroepidemiology, and Biomarkers of Disease. J Alzheimers Dis. 2023;93:991–4.
Zeng LN, Zong QQ, Xu SW, An FR, Ungvari GS, Bressington DT, et al. Oral health in patients with dementia: A meta‐analysis of comparative and observational studies. Int J Geriatric Psychiatry. 2021;36:467–78.
Zhang R-Q, Ou Y-N, Huang S-Y, Li Y-Z, Huang Y-Y, Zhang Y-R, et al. Poor oral health and risk of incident dementia: A prospective cohort study of 425,183 participants. J Alzheimers Dis. 2023;93:977–90.
Ferraro S, Panteghini M. Making new biomarkers a reality: the case of serum human epididymis protein 4. Clin Chem Lab Med. 2019;57:1284–94.
Bai F, Li T, Li B, Li X, Zhu L. Serum Human Epididymis Protein 4 Level is Associated with Cognitive Function in Patients with Diabetes Mellitus. Diabetes Metab Syndr Obes. 2020;13:3919–24.
Reyes J, Yap GS. Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis. J Immunol. 2023;210:5–11.
Jiang WW, Zhang ZZ, He PP, Jiang LP, Chen JZ, Zhang XT, et al. Emerging roles of growth differentiation factor-15 in brain disorders (Review). Exp Ther Med. 2021;22:1270.
Beydoun MA, Noren Hooten N, Weiss J, Beydoun HA, Georgescu M, Freeman DW, et al. GDF15 and its association with cognitive performance over time in a longitudinal study of middle-aged urban adults. Brain Behav Immun. 2023;108:340–9.
Stemmler A, Symmank J, Steinmetz J, von Brandenstein K, Hennig CL, Jacobs C. GDF15 Supports the Inflammatory Response of PdL Fibroblasts Stimulated by P. gingivalis LPS and Concurrent Compression. Int J Mol Sci. 2021;22:13608.
Li Y, Messina C, Bendaoud M, Fine DH, Schreiner H, Tsiagbe VK. Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. Mol Oral Microbiol. 2010;25:275–92.
Losch L, Stemmler A, Fischer A, Steinmetz J, Schuldt L, Hennig CL, et al. GDF15 Promotes the Osteogenic Cell Fate of Periodontal Ligament Fibroblasts, thus Affecting Their Mechanobiological Response. Int J Mol Sci. 2023;24:10011.
Symmank J, Zimmermann S, Goldschmitt J, Schiegnitz E, Wolf M, Wehrbein H, et al. Mechanically-induced GDF15 Secretion by Periodontal Ligament Fibroblasts Regulates Osteogenic Transcription. Sci Rep. 2019;9:11516.
Giudici KV, de Souto Barreto P, Guyonnet S, Morley JE, Nguyen AD, Aggarwal G, et al. TNFR-1 and GDF-15 Are Associated With Plasma Neurofilament Light Chain and Progranulin Among Community-Dwelling Older Adults: A Secondary Analysis of the MAPT Study. J Gerontol A Biol Sci Med Sci. 2023;78:569–78.
Casanova R, Anderson AM, Barnard RT, Justice JN, Kucharska-Newton A, Windham BG, et al. Is an MRI-derived anatomical measure of dementia risk also a measure of brain aging? Geroscience. 2023;45:439–50.
He L, de Souto Barreto P, Sanchez Sanchez JL, Rolland Y, Guyonnet S, Parini A, et al. Prospective Associations of Plasma Growth Differentiation Factor 15 With Physical Performance and Cognitive Functions in Older Adults. J Gerontol A Biol Sci Med Sci. 2022;77:2420–8.
Wu PF, Zhang XH, Zhou P, Yin R, Zhou XT, Zhang W. Growth Differentiation Factor 15 Is Associated With Alzheimer’s Disease Risk. Front Genet. 2021;12:700371.
McGrath ER, Himali JJ, Levy D, Conner SC, DeCarli C, Pase MP, et al. Growth Differentiation Factor 15 and NT-proBNP as Blood-Based Markers of Vascular Brain Injury and Dementia. J Am Heart Assoc. 2020;9:e014659.
Jiang J, Trollor JN, Brown DA, Crawford JD, Thalamuthu A, Smith E, et al. An inverse relationship between serum macrophage inhibitory cytokine-1 levels and brain white matter integrity in community-dwelling older individuals. Psychoneuroendocrinology. 2015;62:80–8.
Jiang J, Wen W, Brown DA, Crawford J, Thalamuthu A, Smith E, et al. The relationship of serum macrophage inhibitory cytokine-1 levels with gray matter volumes in community-dwelling older individuals. PLoS One. 2015;10:e0123399.
Andersson C, Preis SR, Beiser A, DeCarli C, Wollert KC, Wang TJ, et al. Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke. Stroke. 2015;46:2568–75.
Gong T, Tong Q, He H, Sun Y, Zhong J, Zhang H. MTE-NODDI: Multi-TE NODDI for disentangling non-T2-weighted signal fractions from compartment-specific T2 relaxation times. Neuroimage. 2020;217:116906.
Guerrero JM, Adluru N, Bendlin BB, Goldsmith HH, Schaefer SM, Davidson RJ, et al. Optimizing the intrinsic parallel diffusivity in NODDI: An extensive empirical evaluation. PLoS One. 2019;14:e0217118.
Bouyagoub S, Dowell NG, Gabel M, Cercignani M. Comparing multiband and singleband EPI in NODDI at 3 T: what are the implications for reproducibility and study sample sizes? MAGMA. 2021;34:499–511.
Acknowledgements
The authors would like to thank the UK biobank investigators, staff and participants, as well as the staff and analysts from the UK biobank access management system. This work uses data provided by patients and collected by the NHS as part of their care and support. This research also used data assets made available by National Safe Haven as part of the Data and Connectivity National Core Study, le d by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (research which commenced between 1st October 2020 – 31st March 2021 grant ref MC_PC_20029; 1st April 2021 - 30th September 2022 grant ref MC_PC_20058). Importantly, this research has been conducted using the UK Biobank Resource under Application Number 77963. Dr. Hind A. Beydoun worked on this manuscript outside her tour of duty at the U.S. Department of Veterans Affairs.
Funding
This work was supported in part by the Intramural Research Program of the NIH, National Institute on Aging, National Institutes of Health project number AG000513. Open access funding provided by the National Institutes of Health.
Author information
Authors and Affiliations
Contributions
May A. Beydoun: Study concept, data acquisition, plan of analysis, data management and statistical analysis, literature search and review, write-up of parts of the manuscript, revision of the manuscript. Hind A. Beydoun: Study concept, plan of analysis, assistance with data management and statistical analysis, literature search and review, write-up of parts of the manuscript, revision of the manuscript. Yi-Han Hu: Plan of analysis, assistance with data management, data visualization, write-up of parts of the manuscript, revision of the manuscript. Zhiguang Li: Plan of analysis, assistance with data management, data visualization, write-up of parts of the manuscript, revision of the manuscript. Michael F. Georgescu: Plan of analysis, assistance with data management, literature search and review, revision of the manuscript. Nicole Noren Hooten: Study concept, plan of analysis, literature search and review, write-up of parts of the manuscript, review of the manuscript. Jordan Weiss: Literature search and review, write-up of parts of the manuscript, revision of the manuscript. Mustapha Bouhrara: Literature search and review, write-up of parts of the manuscript, revision of the manuscript. Lenore J. Launer: Plan of analysis, literature search and review, write-up of parts of the manuscript, revision of the manuscript. Michele K. Evans: Data acquisition, plan of analysis, write-up of parts of the manuscript, revision of the manuscript. Alan B. Zonderman: Data acquisition, plan of analysis, write-up of parts of the manuscript, revision of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
The studies involving human participants were reviewed and approved by the UK Biobank which has approval from the Institutional Review Boards, namely, the North West Multi-center Research Ethics Committee for the United Kingdom, from the National Information Governance Board for Health and Social Care for England and Wales, and from the Community Health Index Advisory Group for Scotland. All participants gave informed consent for the study via a touch-screen interface that required agreement for all individual statements on the consent form as well as the participant’s signature on an electronic pad. Written informed consent for participation was not required for this study in accordance with the National Legislation and the Institutional Requirements.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Beydoun, M.A., Beydoun, H.A., Hu, YH. et al. Mediating and moderating effects of plasma proteomic biomarkers on the association between poor oral health problems and brain white matter microstructural integrity: the UK Biobank study. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02678-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41380-024-02678-3